Results 11 to 20 of about 3,531,639 (330)
Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)–Specific CD8+ T Cells in Chronic HBV Infection [PDF]
BACKGROUND Strategies that target functional recovery of exhausted hepatitis B virus (HBV)-specific CD8+ T cells are beneficial for viral control, but the potential for interleukin 21 (IL-21) to rescue CD8+ T-cell function is not well understood ...
Libo Tang +13 more
openalex +2 more sources
Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection. [PDF]
Zander R +12 more
europepmc +2 more sources
Obesity and childhood asthma in male schoolchildren in Saudi Arabia: Is there a role for leptin, interleukin-4, interleukin-5, and interleukin-21? [PDF]
BACKGROUND: Adiposity is associated with high serum levels of adipokines and chemokines which are possibly implicated in a co-existence of obesity and asthma.
Al-Ayed M +12 more
europepmc +2 more sources
Interleukin-21 Signaling: Functions in Cancer and Autoimmunity [PDF]
Abstract Interleukin-21 (IL-21) is a cytokine with structural and sequence homology to IL-2 and IL-15, yet possesses several biological properties distinct from these cytokines. IL-21 is produced mainly by activated CD4+ T cells and natural killer T cells and mediates its activity by binding to the IL-21 receptor (IL-21R), consisting of ...
Ian D. Davis +5 more
openalex +5 more sources
Interleukin 21 Receptor Affects Adipogenesis of Human Adipose-Derived Stem/Stromal Cells. [PDF]
Falavinha BC +7 more
europepmc +3 more sources
The IL21 heteromeric receptor complex can activate JAK1 and JAK3 in response to Interleukin-21 (IL21), leading to JAK tyrosine phosphorylation (Asao et al. 2001, Habib et al. 2002).
B. Meldal, S. Jupe
semanticscholar +2 more sources
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD. [PDF]
Shanley M +33 more
europepmc +2 more sources
The effects of interleukin-21 in the biology of transplant rejection. [PDF]
Zeng X, Pan Y, Xia Q, He K.
europepmc +3 more sources

